eFoodSafety.com, Inc. Announces: Expanded Study Results Confirm Additional Benefits from Cinnechol(TM) in Reducing Blood Pressure as Well as Cholesterol Levels

Scottsdale, AZ - (WORLD STOCK WIRE) - September 27, 2007 -- eFoodSafety.com, Inc. (OTCBB:EFSF) is pleased to confirm that during the initial phase of testing Cinnechol(TM) for the treatment of elevated cholesterol, an expanded study showed a very strong and totally unexpected benefit of reducing blood pressure among study participants showing symptoms of hypertension. Within this group taking Cinnechol(TM), blood pressure levels had dropped to normal levels within a short period of time even though the individuals had not expected or taken any other action to accomplish this goal.

For those taking Cinnechol(TM), study data showed an average 18% drop in systolic pressure and an average 15% drop in diastolic pressure. For some participants, results were recorded in as little as two weeks. These unexpected results came in addition to data that showed that participants using Cinnechol(TM) also experienced anticipated decreases in total cholesterol, LDL cholesterol, and triglycerides.

The positive results for Cinnechol(TM) in treating chronic hypertension reveal more comprehensive potential for Cinnechol(TM) than originally anticipated in treating elevated cholesterol. The results strongly support the value in the company's decision to expand clinical testing of Cinnechol(TM).

"The discovery of Cinnechol(TM)'s potential in treating high-blood pressure is an exciting and unexpected development from a product already showing great promise in treating elevated cholesterol," stated Patricia Gruden, President and CEO. "We expect these results to add significantly to the market potential of Cinnechol(TM) and the health benefits it offers to aging populations worldwide."

Hypertension, also known as the "silent killer," affects one out of every three adult Americans over the age of 20. High blood pressure is a major risk factor for heart disease, stroke, congestive heart failure, and kidney disease.

According to the Center for Disease Control, 90% of middle-age adults will develop high blood pressure during their lifetime. Unfortunately, because hypertension often occurs without any symptoms, serious damage can occur in the body before palliative measures are taken. From 1994 to 2004 the death rate from high blood pressure increased 15.5%, and the actual number of deaths from hypertension rose 41.8%. The approximate cost, both direct and indirect, of high blood pressure in the U.S. for 2006 was $63.5 billion.

Other factors in addition to hypertension, all related to heart disease, will also now be examined in the Cinnechol(TM) study. These include levels of homocysteine, a key marker which can predict future heart attacks, and levels of C Reactive Protein (CRP), a marker indicating inflammation within the vessel walls. By its apparent ability to assist the body in normalizing all facets of heart and blood vessel function, Cinnechol(TM) may in fact be an all-in-one answer which can benefit over 100 million Americans.

About eFoodSafety.com, Inc.

eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The OraPhyte(TM) product which has been tested and shown to be effective at eradicating nematodes by the U.S. Department of Agriculture is currently at three major universities with outstanding Agricultural Departments undergoing crop-specific research.

The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn(TM)-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn(TM) line.

The Company is also owner of Cinnergen(TM), a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com) and Cinnechol(TM), a multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The Company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect(TM) anti-acne skin care system.

Please visit the Company's website at: http://www.efoodsafety.com.

Safe Harbor Forward-Looking Statements
Statements contained in this release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.



Patricia Gruden
efoodsafety.com, Inc.
7702 East Doubletree Ranch Road
Suite 300
Scottsdale, AZ 85258
USA

Phone: 415-884-0348
Fax: 480-348-3999


Source: efoodsafety.com, Inc.
Note: The following press release was submitted by: efoodsafety.com, Inc., and World Stock Wire, Inc. is not liable for the contents of this press release.